medigraphic.com
Colegio de Medicina Interna de México.

2012, Number 6

<< Back Next >>

Med Int Mex 2012; 28 (6)

Protein diet for patients with diabetes type 2

Moreno EB, Casanueva FF, Bellido GD, Bellón RA, Sajoux I, Goday AA

Language: Spanish
References: 33
Page: 573-578
PDF size: 167.21 Kb.


ABSTRACT

The loss of weight through diet and exercise, is one of the main therapeutic strategies recommended on the guidelines for the treatment of diabetes type 2 patients with overweight or obesity. The Very Low Calorie Diets (VLCD) such as the Protein Diet, they can be a very good option in obese patients with diabetic type 2 due to they produce a very fast loss of weight and a smaller waist circumference, and at the same time it’s possible to produce a metabolic improvement in short and long term. The reduction of the caloric intake, as well as the limited consumption of carbohydrates it’s the key that leads to ketosis, and at the same time it’s able to improve the metabolic control if it is compared with another types of diets, even when the loss of weight is the same, due to the reduction in the hepatic glucose production and an increase in sensitivity to insulin. This type of diets also are able to improve another problems such as hypertension and Dyslipidemia, that could accelerate the development of diabetes complications. Currently, the Protein Diet as a “Very Low Calorie Diet (VLCD) “constitute an efficient and safe choice for the treatment of the obese type 2 diabetic patients, when it happens under appropriate medical supervision.


REFERENCES

  1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemia. Nature 2001;414:782-7.

  2. Soriguer F, Goday A, Bosch-Comas A, Bordiú E, Calle-Pascual A, Carmena R et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia 2012;55:88-93.

  3. Hussain A, Claussen B, Ramachandran A, Williams R. Prevention of type 2 diabetes: a review. Diabetes Res Clin Pract 2007;76:317-326.

  4. Ford ES, Williamson DF, Liu S. Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiol 1997;146:214-222.

  5. Carey V, Walters E, Colditz G, Solomon C, Willet W, Rosner B, et al. Body Fat Distribution and Risk of Non-Insulin-dependent Diabetes Mellitus in Women: The Nurses' Health Study. Am J Epidemiol 1997;145(7):614-619.

  6. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004;92(3):347-355.

  7. Pittas AG, Joseph NA, Greenberg AS. Adipocytokines and insulin resistance. J Clin Endocrinol Metab 2004;89(2):447-452.

  8. Boden G, Shulman GI. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 2002; 32(Suppl.3):14-23.

  9. American Diabetes Association. Standards of Medical Care in Diabetes-2011. Diabetes Care 2011;34(Suppl 1): S11-S61.

  10. Rubio MA, Salas-Salvadó J, Barbany M, Moreno B, Aranceta J, Bellido D, et al. Consenso SEEDO 2007 para la evaluación del sobrepeso y la obesidad y el establecimiento de criterios de intervención terapéutica. Rev Esp Obes 2007;5:135-175.

  11. Rubio MA, Moreno C. Dietas de muy bajo contenido calórico: adaptación a nuevas recomendaciones. Rev Esp Obes 2004;2:91-98.

  12. Report on tasks for scientific cooperation. Reports of experts participating in SCOOP Task 7.3. Collection of data on products intended for use in very-low-calorie-diets. Report. Brussels: European Commission; September 2002.

  13. Westman EC, Feinman RD, Mavropoulos JC, Vernon MC, Volek JS, Wortman JA, et al. Low-carbohydrate nutrition and metabolism. Am J Clin Nutr 2007;86(2):276-284.

  14. Krieger JW, Sitren HS, Daniels MJ, Langkamp-Henken B. Effects of variation in protein and carbohydrate intake on body mass and composition during energy restriction: a metaregression. AmJ Clin Nutr 2006;83:260-274.

  15. Mullins G, Hallam CL, Broom I. Ketosis, ketoacidosis and very-low-calorie diets: putting the record straight. Nutrition Bulletin 2011;36:397-402.

  16. Farrés J, Pujol A, Coma M, Ruiz JL, Naval J, Mas JM, et al. Revealing the molecular relationship between type 2 diabetes and the metabolic changes induced by a very-low-carbohydrate low-fat ketogenic diet. Nutr Metab (Lond) 2010;7:88.

  17. Calderon A. Epidemiología, genética y mecanismos patogénicos de la diabetes mellitus. Rev Esp Cardiol Supl 2007;7:3H-11H.

  18. Wing RR. Use of very-low-calorie diets in the treatment of obese persons with non-insulin-dependent diabetes mellitus. J Am Diet Assoc 1995;95(5):569-572.

  19. Kelley DE, Wing R, Buonocore C, Sturis J, Polonsky K, Fitzsimmons M. Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1993;77(5):1287-1293.

  20. Uusitupa MI, Laakso M, Sarlund H, Majander H, Takala J, Penttilä I. Effects of a very-low-calorie diet on metabolic control and cardiovascular risk factors in the treatment of obese non-insulin-dependent diabetics. Am J Clin Nutr 1990;51(5):768-773.

  21. Gumbiner B, Wendel JA, McDermott MP. Effects of diet composition and ketosis on glycemia during very-low-energy-diet therapy in obese patients with non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1996;63(1):110-115.

  22. Capstick F, Brooks BA, Burns CM, Zilkens RR, Steinbeck KS, Yue DK. Very low calorie diet (VLCD): a useful alternative in the treatment of the obese NIDDM patient. Diabetes Res Clin Pract 1997;36(2):105-111.

  23. Willi SM, Martin K, Datko FM, Brant BP. Treatment of type 2 diabetes in childhood using a very-low-calorie diet. Diabetes Care 2004;27(2):348-353.

  24. Henry RR, Scheaffer L, Olefsky JM. Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1985;61(5):917-925.

  25. Paisey RB, Frost J, Harvey P, Paisey A, Bower L, Paisey RM, et al. Five year results of a prospective very low calorie diet or conventional weight loss programme in type 2 diabetes. J Hum Nutr Diet 2002;15(2):121-127.

  26. Monnier L, Colette C, Percheron C, Boniface H. Very-lowcalorie-diets: is there a place for them in the management of the obese diabetic?. Diabetes Metab 2000;26 Suppl 3:46-51.

  27. Jazet IM, de Craen AJ, van Schie EM, Meinders AE. Sustained beneficial metabolic effects 18 months after a 30-day very low calorie diet in severely obese, insulin-treated patients with type 2 diabetes. Diabetes Res Clin Pract 2007;77(1):70-76.

  28. Dhindsa P, Scott AR, Donnelly R. Metabolic and cardiovascular effects of very-low-calorie diet therapy in obese patients with Type 2 diabetes in secondary failure: outcomes after 1 year. Diabet Med 2003;20(4):319-324.

  29. Wheeler ML, et al. Macronutrients, Food Groups, and Eating Patterns in the Management of Diabetes. Diabetes Care 2012;35: 434-445.

  30. Goday Arno A, Casanueva Freijó F, Bellido Guerrero D, Sajoux I. Seguridad de la dieta Proteinada para la pérdida de peso en pacientes con diabetes tipo 2 en comparación con una dieta hipocalórica. Resultados preliminares de los primeros 2 meses de tratamiento. XXIII Congreso Nacional de la Sociedad Española de Diabetes. Poster p-025.

  31. Henry RR, Wiest-Kent TA, Scheaffer L, Kolterman OG, Olefsky JM. Metabolic consequences of very-low-calorie diet therapy in obese non-insulin-dependent diabetic and nondiabetic subjects. Diabetes 1986;35(2):155-164.

  32. Amatruda JM, Richeson JF, Welle SL, Brodows RG, Lockwood DH. The safety and efficacy of a controlled low-energy ('verylow-calorie') diet in the treatment of non-insulin-dependent diabetes and obesity. Arch Intern Med 1988;148(4):873-877.

  33. Moreno B, Fondevilla J, Font B, Sajourx I, Sevillano C, Yagüe I. Eficacia del método pronoKal® para la pérdida de peso en comparación con una dieta hipocalórica. Resultados preliminares de los primeros 6 meses. XXXII Congreso de la Sociedad Española de Medicina Interna (SEMI). Póster v-282. Rev Clin Esp 2011;211:450-630.




2020     |     www.medigraphic.com